Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정우진 | - |
dc.date.accessioned | 2016-08-27T04:08:47Z | - |
dc.date.available | 2016-08-27T04:08:47Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.issn | 1791-7530 | - |
dc.identifier.other | OAK-11060 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/216812 | - |
dc.description.abstract | Aim: We aimed to investigate the clinical significance of the activation of Yes-Associated Protein 1 (YAP1), a key downstream effector of Hippo tumor-suppressor pathway, in ovarian cancer. Materials and Methods: A gene expression signature reflecting activation of YAP1 was developed from gene expression data of 267 samples from patients with ovarian cancer. A refined ovarian cancer YAP1 signature was validated in an independent ovarian cancer cohort (n=185). Associations between the YAP1 signature and prognosis were assessed using Kaplan-Meier plots, the log-rank test, and a Cox proportional hazards model. Results: We identified a 612-gene expression signature reflecting YAP1 activation in ovarian cancer. In multivariate analysis, the signature was an independent predictor of overall survival (hazard ratio=1.66; 95% confidence interval=1.1 to 2.53; p=0.01). In subset analysis, the signature identified patients likely to benefit from taxane-based adjuvant chemotherapy. Conclusion: Activation of YAP1 is significantly associated with prognosis and the YAP1 signature can predict response to taxane-based adjuvant chemotherapy in patients with ovarian cancer. | - |
dc.language | English | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.subject | DNA microarrays | - |
dc.subject | ovarian cancer | - |
dc.subject | prognosis | - |
dc.subject | taxane | - |
dc.subject | YAP1 | - |
dc.title | Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer | - |
dc.type | Article | - |
dc.relation.issue | 2 | - |
dc.relation.volume | 34 | - |
dc.relation.index | SCI | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.startpage | 811 | - |
dc.relation.lastpage | 817 | - |
dc.relation.journaltitle | ANTICANCER RESEARCH | - |
dc.identifier.wosid | WOS:000331497200035 | - |
dc.author.google | Jeong, Woojin | - |
dc.author.google | Kim, Sang-Bae | - |
dc.author.google | Sohn, Bo Hwa | - |
dc.author.google | Park, Yun-Yong | - |
dc.author.google | Park, Bun Sung | - |
dc.author.google | Kim, Sang Cheol | - |
dc.author.google | Kim, Sung Soo | - |
dc.author.google | Johnson, Randy L. | - |
dc.author.google | Birrer, Michael | - |
dc.author.google | Bowtell, David S. L. | - |
dc.author.google | Mills, Gordon B. | - |
dc.author.google | Sood, Anil | - |
dc.author.google | Lee, Ju-Seog | - |
dc.contributor.scopusid | 정우진(35914322500) | - |
dc.date.modifydate | 20230411114857 | - |